29
ADVANCES IN THE NUTRITIONAL MANAGEMENT OF HYPERPHOSPHATEMIA AMONG HEMODIALYSIS PATIENTS Rana G. Rizk, PhD, MPH, LD Maastricht University, The Netherlands November, 2017

ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

ADVANCES IN THE NUTRITIONAL MANAGEMENT OF HYPERPHOSPHATEMIA

AMONG HEMODIALYSIS PATIENTS

Rana G. Rizk, PhD, MPH, LD

Maastricht University, The Netherlands

November, 2017

Page 2: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Learning objectives•Review the guidelines and available treatment options for

hyperphosphatemia among hemodialysis patients

• Examine the traditional approach to dietary management of hyperphosphatemia

•Recognize the importance of differentiating between sources of dietary phosphate in hyperphosphatemia management

•Discuss the best approach to dietary management of hyperphosphatemia

Page 3: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Phosphate homoeostasis in humans

Penido & Alon, PediatrNephrol (2012) 27:2039-48

1500 mg

1100 mg

200 mg

900 mg

200 mg

600 mg

Page 4: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Phosphate homoeostasis in CKD

Hruska et al., Kidney Int. 2008; 74(2): 148-57

Page 5: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Hyperphosphatemia in hemodialysis

Egypt: 69.1% Lebanon: 40.4%

Wahbeh et al., 2011; Afifi et al., 2011; Karavetian et al., 2014; Port et al., 2006; Al Aly et al., 2016

Most common single mineral deviation from KDOQI guidelines

Page 6: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Why do we care ?!Hyperphosphatemia & mortality

“Silent killer of hemodialysis

patients”

Block et al., J Am Soc Nephrol. 2004;15: 2208–18

Page 7: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

What is the evidence?

Hyperphosphatemia & adverse outcomes

Hyper-phosphatemia

↑ hospital-izations ↓ physical

functioning

↓ QOL

↑ pill burden

↑ cost

Other

Blayney & Tentori, 2009; Bover et al., 2009; Danese et al., 2008; Floege et al., 2011; Heymann et al., 2012; Hruska et al., 2011; Johansen & Chertow, 2007; Lee et al., 2007; Moorthie & Moe, 2011; Naves-Diaz et al., 2011; Roman-Garcia et al., 2009; Tentori et al., 2008; Young et al., 2004; Young et al., 2005

Page 8: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Hyperphosphatemia management

Optimal dialysisPTH

control

Phosphate binders

Dietary restriction

KDIGO, 2009; KDOQI, 2003

Page 9: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Traditional dietary phosphate restriction20 years ago dietitians emphasized controlling hyperphosphatemia by

absolute dietary phosphate restriction

Page 10: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

What is the evidence? Dietary phosphate restriction & mortality

• Post hoc analysis of data from the Hemodialysis Study (n=1751)•More restrictive phosphate prescription → poorer indices of nutritional status

Lynch et al., Clin J Am SocNephrol. 2011; 6: 620-9

30% ↑ survival

Page 11: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Traditional dietary phosphate restrictionDid we miss anything ?!

Estimated phosphate intake (mg/dl)

calculated from daily protein intake (g/d) in hemodialysis patients from the NIED study

(n=107)

Kalantar-Zadeh et al., CJASN. 2010; 5:519-30

Page 12: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

What is the evidence? Dietary phosphate, protein & mortality

↑protein intake → ↑survival↑↑survival with simultaneous

↓ serum phosphate

Shinaberger et al., Am J Clin Nutr 2008;88:1511–8

The risk of controlling serum phosphate by restricting protein

- may ↑mortality- may outweigh the benefit of

controlled phosphate

n=30,075

Page 13: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Phosphorus-to-protein ratio

Page 14: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Phosphorus-to-protein ratio•Advantages• Simultaneous representation of dietary phosphate & protein• Helps in selecting foods with desirable ratio & not solely based upon phosphate content• Emphasize foods with high amount of phosphate additives but having similar amount of

dietary protein•Does not depend on the food portion being served

•Disadvantages• Sometimes difficult to calculate• Variations & inaccuracies in estimations of phosphate content

•Does not give any information about phosphate bioavailabilityKDOQI, 2003

Page 15: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

What is it with phosphate sources ?!≈100%

40-80%

20-40%

Vervloet et al., Nat Rev Nephrol. 2017; 13:27-38

Page 16: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

What is it with phosphate bioavailability ?!The role of Phytate

Phosphate in meat is easily hydrolyzed & readily absorbed

Phosphate in plants is mostly in phytic

acid or phytate form (75%)

Humans do not express phytase(low phosphate bioavailability:

<50%)

↓ intestinal phosphate

absorption per gram of plant vs. animal-

based protein

Plant foods are less likely to ↑

phosphate burden

Kalantar-Zadeh et al., CJASN. 2010; 5:519-30

Page 17: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

What is it with phosphate bioavailability ?!The role of Phytate

The traditional approach of totally restricting intake of beans, peas, seeds & chocolate is of no major relevance ?

• Important considerations• Even with ↓ fractional rate of intestinal absorption,

↑ intake can still lead to excessive phosphate burden• Some seeds & beans ↑ potassium → hyperkalemia• Yeast-based phytase in whole grains:

↑ absorption of phosphate in leavened breads than cereals or flat breads• Unclear effect of probiotics on phosphate absorption

Kalantar-Zadeh et al., CJASN. 2010; 5:519-30

Page 18: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

What is it with protein digestibility ?!Ratio adjusted for digestion & absorption

Considers digestibility of protein & bioavailability of phosphate

KDOQI, 2009; Beto et al., Int J Nephrol Renovasc Dis. 2016;9:21-33

Protein digestibility

Animal proteins: 95%

Plant proteins: 85%

Mixed meals:85% to 95%

Page 19: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Phosphate bioavailability studies in humans for various dietary protein sources are needed to provide comprehensive evidence-based identification

of preferred dietary sources KDOQI, 2009; Beto et al., Int J Nephrol Renovasc Dis. 2016;9:21-33

Page 20: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Focus on avoiding phosphate additives • Consumption of phosphate additives: ≈ 1000 mg/day• 2 servings of additive-containing chicken products: 880 mg

•Difficult to precisely determine• Food industry is not required to report the quantity used• Only listing the additives used in the ingredient list

• Concerns of underestimation of dietary phosphate intake• Processed foods• ↑ inorganic phosphate load • ↓ nutritional value• Often paired with sodium & potassium additives

Biruete et al., J Ren Nut. 2017;31:62-70

Page 21: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Hidden phosphate !!!

Page 22: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

International survey of renal care professionals

Fouque et al., J Ren Nut. 2014;24:110-5

Page 23: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Focus on avoiding phosphate additives • Cluster RCT

• n=279; with serum phosphorus levels >5.5 mg/dL

• Counseling on avoiding phosphate additives vs. standard recommendations• 30 minutes of education • Reading food labels/ avoiding phosphorus-containing additives when purchasing food• Providing renal-friendly options when eating at fast-food restaurants

Sullivan et al., JAMA. 2009;301:629-35

Page 24: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Executive summary of the 2017 KDIGO CKD-MBD Guideline update: What’s changed and why it matters

Limiting phosphate intakewith phosphate sources as additional qualifier

KDIGO, 2017

Not all Phosphate is created equal

Page 25: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Cooking techniques to reduce phosphate content•Boiling of sliced food using pressure cooker & discarding water• Soaking in cold water (4°C) for 1 hour before thermal processing• Significant reduction of phosphate content while preserving protein content

Ando et al., J Ren Nut.2015;25:504-9

Page 26: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Cooking techniques to reduce phosphate content

• Patients’ feedback• Straightforward processing instructions• Product satisfactory vis-à-vis texture & visual appeal, slightly "bland" taste• "Demineralization" rated positively; "Leaching" & "dialyzing" rated "somewhat negative“, "unappealing"

Jones, J Ren Nut.2001;11:90-6

Page 27: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg
Page 28: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

P/protein ratio

Take-home message

Dietary phosphate restriction

Greater focus on:1) Avoiding added phosphate2) Better appreciating that natural

phosphate is not well absorbed3) Wet cooking techniques4) Diligent use of phosphate binders5) Patient education & counseling

800-1000

mg/day

Judicious dietary phosphate restriction while maintaining adequate dietary protein intake

Toussaint et al., Nephrology. 2017;22,

(Suppl. 2):36–41

P content

P bioavaila

bility

Page 29: ADVANCES IN THE NUTRITIONAL MANAGEMENT OF ...Phosphate homoeostasis in humans Penido & Alon, Pediatr Nephrol (2012) 27:2039-48. 1500 mg. 1100 mg. 200 mg. 900 mg. 200 mg 600 mg

Thank you !